...
首页> 外文期刊>Scientific reports. >Prognostic Significance of Metabolic Parameters and Textural Features on 18F-FDG PET/CT in Invasive Ductal Carcinoma of Breast
【24h】

Prognostic Significance of Metabolic Parameters and Textural Features on 18F-FDG PET/CT in Invasive Ductal Carcinoma of Breast

机译:18F-FDG PET / CT在乳腺癌肠道癌中的代谢参数和纹理特征的预后意义

获取原文
   

获取外文期刊封面封底 >>

       

摘要

To investigate the prognostic significance of metabolic parameters and texture analysis on sup18/supF-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in patients with breast invasive ductal carcinoma (IDC), from August 2005 to May 2015, IDC patients who had undergone pre-treatment FDG PET/CT were enrolled. The metabolic parameters, including maximal standardized uptake value of breast tumor (SUVbt) and ipsilateral axillary lymph node (SUVln), metabolic tumor volume (MTVbt) and total lesion glycolysis (TLGbt) of breast tumor, whole-body MTV (MTVwb) and whole-body TLG (TLGwb) were recorded. Nine textural features of tumor (four co-occurrence matrices and five SUV-based statistics) were measured. The prognostic significance of above parameters and clinical factors was assessed by univariate and multivariate analyses. Thirty-five patients were enrolled. Patients with low and high MTVwb had 5-year progression-free survival (PFS) of 81.0 and 14.3% (p??0.0001). The 5-year overall survival for low and high MTVwb was 88.5% and 43.6% (p?=?0.0005). Multivariate analyses showed MTVwb was an independent prognostic factor for PFS (HR: 8.29, 95% CI: 2.17-31.64, p?=?0.0020). The SUV, TLG and textural features were not independently predictive. Elevated MTVwb was an independent predictor for shorter PFS in patients with breast IDC.
机译:从8月到2005年8月到2005年8月,探讨乳腺侵入性导管癌(IDC)患者中代谢参数和纹理分析对乳腺侵袭性导管癌(IDC)患者的预后显着性2015年5月,已招收经过治疗前治疗FDG PET / CT的IDC患者。代谢参数,包括乳腺肿瘤(SUVBT)和同侧腋窝淋巴结(SUVLN)的最大标准化摄取值,代谢肿瘤体积(MTVBT)和乳腺肿瘤的总损伤糖酵解(TLGBT),全身MTV(MTVWB)和整体-Body TLG(TLGWB)被记录。测量肿瘤(四种共发生矩阵和五种基于SUV基统计学)的九种纹理特征。通过单变量和多变量分析评估了上述参数和临床因素的预后意义。三十五名患者注册。低MTVWB的患者具有81.0和14.3%(P≤0.0001)的5年的无进展存活率(PFS)。低和高MTVWB的5年总生存率为88.5%和43.6%(p?= 0.0005)。多变量分析显示MTVWB是PFS的独立预后因素(HR:8.29,95%CI:2.17-31.64,P?= 0.0020)。 SUV,TLG和纹理特征没有独立预测。升高的MTVWB是乳房IDC患者较短PFS的独立预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号